Tytuł artykułu

Clinical, endoscopic and histopathological evaluation of the efficacy of budesonide in the treatment of inflammatory bowel disease in dogs

Tytuł czasopisma

Polish Journal of Veterinary Sciences

Rocznik

2016

Numer

No 1

Autorzy

Rychlik, A. ; Kołodziejska-Sawerska, A. ; Nowicki, M. ; Szweda, M.

Wydział PAN

Nauki Biologiczne i Rolnicze

Wydawca

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Data

2016

Identyfikator

DOI: 10.1515/pjvs-2016-0020 ; ISSN 1505-1773

Źródło

Polish Journal of Veterinary Sciences; 2016; No 1

Referencje

Otley (2005), Budesonide for induction of remission in Crohn s disease CD, Cochrane Database Syst Rev, 4. ; Papi (2000), Budesonide in the treatment of Crohn s disease : a meta - analysis, Aliment Pharmacol Ther, 14. ; Craven (2004), Canine inflammatory bowel disease : retrospective analysis of diagnosis and outcome in cases, J Small Anim Pract, 45. ; Jergens (2012), Inflammatory bowel disease in veterinary medicine ( Elite, Front Biosci, 4, 1404, doi.org/10.2741/e470 ; Day (2008), Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat : a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group, J Comp Pathol, 138. ; Tumulty (2004), Clinical effects of short - term oral budesonide on the hypothalamic - pituitary - adrenal axis in dogs with inflammatory bowel disease, J Am Anim Hosp Assoc, 40. ; Gross (1996), lmerich Oral pH - modified release budesonide versus - methylprednisolone in active Crohn s disease German / Austrian Budesonide Study Group, Eur J Gastroenterol Hepatol, 6. ; Angelucci (2008), Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment, Curr Med Chem, 15. ; Campieri (1997), Oral budesonide is as effective as oral prednisolone in active Crohn s disease The Global Budesonide Study Group, Gut, 41. ; Jergens (2003), A scoring index for disease activity in canine inflammatory bowel disease, J Vet Intern Med, 17. ; Rutgeerts (1994), A comparison of budesonide with prednisolone for active Crohn s disease, N Engl J Med, 331. ; Meir (1998), Bar Budesonide versus prednisone in the treatment of active Crohn s disease The Israeli Budesonide Study Group, Gastroenterology, 115. ; Simpson (2011), Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease, Vet Clin North Am Small Anim Pract, 41. ; Malewska (2011), Treatment of inflammatory bowel disease IBD in dogs and cats, Pol J Vet Sci, 14. ; Pietra (2013), Plasma concentrations and therapeutic effects of budesonide in dogs with inflammatory bowel disease, Am J Vet Res, 74. ; Simms (2001), Budesonide for maintenance of remission in Crohn s disease CD, Cochrane Database Syst Rev, 1. ; Seow (2008), Budesonide for induction of remission in Crohn s disease CD, Cochrane Database Syst Rev, 3.